CRWV CRWV
“CoreWeave is growing fast but losing money, drowning in debt, and just filed paperwork to sell more stock — while insiders keep selling”
CoreWeave is growing fast but losing money, drowning in debt, and just filed paperwork to sell more stock — while insiders keep selling. At $100 it's sitting right on a key support line, so it could bounce toward the $140 analyst target, but it could just as easily get cut in half if H2 execution slips. Best to wait for either a clean bounce off support with volume or a capital raise to clear the overhang before committing.
starter only if initiating — prefer no position; 91% annualized vol and equity shelf overhang make sizing dangerous
Revenue is growing 111.6% YoY into a reported $99.4B backlog with Anthropic/Meta wins, and consensus analyst target of $140.18 implies ~40% upside from $100.39. The stock is sitting on its 200-DMA ($99.93) after a -27.24% one-month washout, a level where contrarian bounces and short squeezes are plausible given 91% annualized vol.
- no items
- ·Analyst consensus target of $140 (~40% upside) could catalyze a sharp reversal if sentiment shifts positive
- ·Hyperscaler AI capex surge could extend CoreWeave's revenue runway beyond current expectations
- ·Short squeeze risk given volatile nature and high short interest plausible in a stock down 28% over 1 year
- ·Contract concentration: if Microsoft or other anchor tenants renew/expand, revenue visibility improves dramatically
- ·Macro risk: any AI spending pullback or GPU supply normalization could accelerate losses and refinancing pressure
Forward PE of -143x, profit margin of -25.6%, and debt-to-equity of 738x describe a company funding GPU capex with leverage it cannot service from operations. The June 5 mixed shelf filing plus uninterrupted insider selling telegraphs near-term dilution, and Q2 guidance loads ~90% of FY adjusted operating income into H2 — an execution bar the critic correctly flags as inconsistent with -$4.71B Q1 FCF and $31–35B annual capex. Price is below the 50-DMA ($106.74) with -27.24% 1M momentum, and bear analyst targets reach $36–67.
Resolves by Jul 22, 2026 · 02:07. Falsifiers: Clean break and close below 200-DMA ($99.93) on volume, or any equity raise priced below $90, flips this to SELL; Anchor-tenant contract expansion (Microsoft/Meta/Anthropic) or H2 operating income tracking confirmed above guide midpoint flips to BUY; Insider buying or withdrawal/non-use of the June 5 shelf within 60 days materially reduces dilution overhang
- ·Deeply unprofitable: trailing net margin of -25.6% with no path to profitability visible in forward estimates (fwd PE of -143x)
- ·Extreme leverage: debt-to-equity of 738x signals massive GPU financing obligations relative to thin equity base
- ·Revenue growth of 111% YoY is impressive but priced in and may reflect backloaded contract recognition risk
- ·Price ($100.39) is below 50-day MA ($106.74), indicating near-term downtrend
- ·1-month return of -27.24% signals sharp recent selling pressure
- ·Annualized volatility of 91% reflects extreme risk regime
- ·Q1 2026 (May 7, ~31 days ago): Revenue beat ($2.08B vs $1.97B expected, +112% YoY) but EPS miss (-$1.12 adj vs -$0.90 expected); stock fell ~10-13% post-earnings (CNBC, timothysykes.com)
- ·Q2 2026 guidance soft ($2.45B-$2.60B midpoint vs $2.69B consensus) and FY CapEx raised to $31B-$35B — puts heavy weighting on H2 execution (TheStreet/Wells Fargo, May 8)
- ·RECENT (June 5, 2 days ago): Another insider sale flagged; Director Jack D. Cogen sold 742,307 shares for ~$78.7M on May 29; insiders have ONLY sold in past 3 months with zero open-market buys (TipRanks, SimplyWallSt)
- 01yfinanceFundamental
- 02cnbc.comNews
- 03timothysykes.comNews
- 04timothysykes.comNews
- 05tipranks.comNews
- 06tipranks.comNews
- 07thestreet.comNews
- 08tipranks.comNews
- 09quiverquant.comNews
- 10simplywall.stNews
- 11simplywall.stNews
- 12kavout.comNews
- 13cnn.comNews
- 14public.comNews
- 15stockanalysis.comNews